It has often been said that his main skills are in raising capital - maybe those skills are not needed anymore...
Printable View
Smoke and mirrors won't fool the faithful by May 2022 when results are published. There will be unhappiness and disbelief next month with the publication of the 2021 results but Dave will have worked out excuses for those. But not next year. A year to sell down. All good.
CxB will then be taken out by big Pharma and become Gold standard. How's that?
He's done an incredible job keeping the wheels on till now.
If people are expecting a profit this financial year they are deluded and should get out.
Profit?!! What's that? No, it'll be test throughput and revenue growth that'll disappoint.